Peginterferon alfa-2a (Pegasys)
- BNF:
- Infections
- Status:
- Red
- Decision Date:
- None
Comments
RED1,2,3,8: NICE TA300 - Peginterferon alfa and ribavirin for treating chronic hepatitis C in children and young people (decision date - December 2013)
RED: treatment of HBeAg-positive chronic hepatitis B infection (decision date - January 2018)
Red Drug Classifications
- 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating
- 2: Requiring long term on-going monitoring of efficacy by a specialist and not suitable for shared care
- 3: Requiring long term on-going monitoring of toxicity by a specialist (either because of difficulty in recognising side effects or high cost of investigations to identify toxicity)
- 8. NHS England commissioned – to be used in line with NHSE commissioning intentions
search again